The use of fluoroscopic guidance for transbronchial biopsy (TBB) during flexible fiberoptic bronchoscopic examination has been controversial. Patient records and bronchoscopy reports for 112 transbronchial biopsies performed with fluoroscopy over a seven-year period were reviewed and compared with those of 135 transbronchial biopsies performed without fluoroscopy over the same interval. Complication rates with regard to pneumothorax, fever, and hemorrhage were compared, as were yield data for neoiberoptic bronchoscopy and transbronchial biopsy (TBB) are commonly used in the diagnostic approach to many pulmonary disorders. [1] [2] [3] [4] [5] [6] [7] With such widespread application, bronchoscopists have disagreed as to the necessity of fluoroscopic guidance in TBB.8'9 For a number of years the American Thoracic Society has recommended in its official position paper on bronchoscopy that TBB be performed only under fluoroscopic control, although very recently the ATS has deleted that statement. 10 The safety ofTBB without fluoroscopy has been demonstrated in several recent studies. [11] [12] [13] This report compares the complication rate and yield data of 135 cases of TBB performed without fluoroscopy with 112 cases in which fluoroscopy was used, all over a seven-year period at one institution. This report suggests that TBB without fluoroscopy (in the basilar segments) is safe and that diagnostic yield, particularly in sarcoidosis and diffuse neoplasm, is good. (Chest 1988; 94:557-60) specimen obtained by TBB, the specimen slides were reviewed by a histopathologist and one of the authors. The procedural complications evaluated during the record review were pneumothorax, hemorrhage, and fever. Pulmonary hemorrhage was defined as frank blood coughed up within 24 hours after the procedure. Fever was defined as temperature elevation greater than 37°C within 24 hours of the procedure. In addition to assessing the procedural complications, the diagnostic yield of each TBB was evaluated. In all cases, a determination was made as to whether alveolar tissue was obtained in the biopsy specimen. For purposes of analysis the patients were then divided into three diagnostic groups: neoplasm, sarcoidosis, and miscellaneous other conditions. The majority of the patients were in the first two groups, which the TBB was considered to confirm the diagnosis if tumor or noncaseating granulomas, respectively, were found on TBB. The third group was composed of small numbers of many different diagnoses, including pulmonary infections, interstitial lung disease, vasculitides, etc. Some of these diseases in retrospect were not amenable to diagnosis or to confirmation by TBB. Hence, in this group, it was arbitrarily decided that the TBB was diagnostic in either of the following cases: (1) a specific histopathologic entity diagnosable by TBB was found (eg, Pneumocystis carinii pneumonia) or (2) alveolar tissue was obtained, and based on this and the clinical setting, diagnostic certainty was sufficient not to proceed with other invasive tests, and the provisional diagnosis was considered as final.
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Statistical Analysis
Complication rates and relative diagnostic yields were compared between patient groups done with and without fluoroscopy. Results were also compared with similar groups of patients described in the medical literature. Statistical differences in proportions between groups of patients were determined by the x2 test.
Methodology of Transbronchial Biopsy
The specific TBB methodology used in most patients undergoing the procedure without fluoroscopy was as follows: after the appropriate subsegmental bronchus was endoscopically selected, the patient was instructed to inhale deeply, and the forceps were extended 2.5 to 5 cm into the bronchus. The patient was instructed to exhale and then inhale again. As the second deep inhalation was performed, the forceps were opened and advanced an additional 2.5 to 5 cm or until resistance was met. The patient was instructed to exhale against the open forceps, the forceps were closed, and the patient was asked if this produced any chest pain. If the patient indicated pain, the forceps were opened and the process repeated from the level of the visualized subsegmental bronchus. Postprocedure chest roentgenograms were obtained within two or more hours, and in most patients, within four hours if fluoroscopy was not used. Fluoroscopy and in some cases roentgenograms were used to determine the presence of a pneumothorax where fluoroscopic guidance was used. In general, basilar segments underwent biopsy to avoid the interlobar fissures where the biopsy forceps might penetrate visceral pleura without encountering parietal pleura where the pleura pain fibers are located.
RESULTS
A total of 1, 232 fiberoptic bronchoscopic procedures were performed during this study period, of which 247 patients underwent TBB. Bronchoscopic reports were available for all of these patients. Inpatient and outpatient records were found and reviewed in 226 cases. Where patient records were sparse, actual postprocedure chest roentgenograms were reviewed in 34 cases and patlhology specimen slides in 33 cases; patient and/or physician interviews were conducted in 57 cases. The patients' mean age was 52.3 years, and 57 percent were men. Indications for bronchoscopy and TBB included pulmonary infiltrates, hilar adenopathy, parenchymal mass lesions, distinct interstitial patterns visualized on chest roentgenograms, hemoptysis, unexplained dyspnea, and fever in an immunocompromised host.
One hundred twelve biopsies were performed with fluoroscopic guidance and 135 without fluoroscopy. Two hundred thirty-five of these bronchoscopies were performed via the transnasal approach. Only six procedures were performed on outpatients, all done without fluoroscopy Table 1 lists the lobar distribution of the TBBs in each group. The majority of TBBs performed without fluoroscopy were done in the lower lobes (120 of 135), while 51 of 112 with fluoroscopy were in the lower lobes. Table 2 gives the final diagnosis of the patients undergoing TBB as part oftheir evaluation. Sarcoidosis and neoplasm were the most common diagnoses overall.
Complications of transbronchial biopsies in both groups are listed in Table 3 . Only one patient devel- Table 5 lists the relative yield data for neoplasm. The data are subdivided based on whether the radiographic abnormality was diffuse (eg, lymphangitic spread) or focal (one or more nodules or masses). When the lung was diffusely involved, the yield without fluoroscopy was similar to that with fluoroscopy, but it was significantly reduced when the disease was focal. Table 6 shows the diagnostic yield for noncaseating granulomas in patients with sarcoidosis by stage. Overall, there was no significant difference in diagnostic yield between the two groups.
There were 30 patients with miscellaneous diagno- ses other than sarcoidosis and neoplasm in the group of biopsy with fluoroscopy and 37 in the group of biopsy without fluoroscopy In each group, by the criteria listed above, the diagnostic yield was 76.7 percent and 70.3 percent, respectively (not significantly different). The tissue obtained in most of these instances was not specific for the final diagnosis, but was sufficiently supportive of the diagnosis that no further invasive diagnostic procedures were deemed essential.
Combining all the categories, the diagnostic yield for the 112 patients who underwent biopsy with fluoroscopy was 72.3 percent, and for the 135 who had biopsy without fluoroscopy it was 67.4 percent. These proportions were not significantly different.
DIscusSION
Since the introduction of the flexible fiberoptic bronchoscope in the 1970s, its utility as a diagnostic tool with the use of TBB has dramatically increased. The use of fluoroscopy during TBB has been a matter of contention for several years, raising the question of safety as well as yield.8.9 The recent studies ofPrigogine and Schmerber,14 also involving diffuse lung disease not limited to sarcoidosis, showed rates ofcomplication similar to those of our series, albeit with smaller numbers of patients reported.
It is also important to compare complication rates of procedures done without fluoroscopy with biopsies performed using fluoroscopy over the same seven-year period. In-our study, the rates of complication for both of these groups were low In addition, TBB was performed by multiple operators with varying degrees of experience (although always under supervision of more experienced bronchoscopists). In regard to pneumothorax and the postbronchoscopic chest roentgenogram, personal follow-up with many of these patients who underwent TBB without fluoroscopy failed to reveal any significant complications. The majority of postbiopsy chest roentgenograms were obtained within four hours of the procedure. This appears to be a reasonable time for evaluation for a pneumothorax. 16 When compared with previous studies the complication rates in this study compare favorably.3'5,7"13"14
The question of relative yield is more complex. The medical literature has reflected a growing acceptance ofTBB without fluoroscopy in the diagnosis of sarcoidosis. 11, 13 Diagnosis in sarcoidosis may frequently be made from bronchial as well as alveolar tissue, so the relatively high yield in sarcoidosis is not surprising. The relative yield data in neoplasm in this study deserves additional comment. The percentage yield ofTBB with fluoroscopy (72.9 percent) vs TBB without fluoroscopy (52.5 percent) suggests that fluoroscopy enhances the diagnostic yield. The majority of lesions biopsied under fluoroscopy in this study were localized, leading bronchoscopists to use fluoroscopy selectively in these cases. However, as is demonstrated in Table 5 , the yield data in diffuse disease diagnosed by TBB alone are not significantly different for fluoroscopy and nonfluoroscopy groups. We believe, like other authors,5 that fluoroscopy does enhance yield in distinct lesions that are not visible endobronchially The increased yield in localized disease with fluoroscopic guidance is well demonstrated by our data (Table 5) , and the importance of fluoroscopy in increasing yield in localized disease not endobronchially visible must be emphatically stated. Our numbers of patients with other diffuse pulmonary disease that can be diagnosed by TBB were too small for meaningful evaluation. One group of particular interest for future study is immunosuppressed patients with diffuse infiltrates to determine whether fluoroscopy influences safety and yield. Our data support the contention that TBB in the basilar segments without fluoroscopy by the transnasal approach, particularly in the sarcoidosis and neoplasm subgroups, is a safe diagnostic procedure with a reasonable diagnostic yield. Fluoroscopy can be reserved for occasions when the biopsy must be done in the upper or middle lobe or when localized disease is present, without compromising diagnostic yield.
